In This Article:
Over the last 7 days, the market has dropped 1.9%, but it is up 21% over the past year with earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks that can capitalize on these favorable conditions is crucial for investors looking to maximize their returns.
Top 10 High Growth Tech Companies In The United States
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| TG Therapeutics | 28.39% | 43.54% | ★★★★★★ |
| Sarepta Therapeutics | 24.22% | 44.94% | ★★★★★★ |
| Super Micro Computer | 20.62% | 27.13% | ★★★★★★ |
| Ardelyx | 27.44% | 65.50% | ★★★★★★ |
| G1 Therapeutics | 27.57% | 57.75% | ★★★★★★ |
| Invivyd | 42.91% | 70.39% | ★★★★★★ |
| Amicus Therapeutics | 20.45% | 61.85% | ★★★★★★ |
| Clene | 73.06% | 62.58% | ★★★★★★ |
| Seagen | 22.57% | 71.80% | ★★★★★★ |
| ImmunoGen | 26.00% | 45.85% | ★★★★★★ |
Click here to see the full list of 249 stocks from our US High Growth Tech and AI Stocks screener.
Let's explore several standout options from the results in the screener.
Aldeyra Therapeutics
Simply Wall St Growth Rating: ★★★★★☆
Overview: Aldeyra Therapeutics, Inc. is a biotechnology company focused on developing and commercializing medicines for immune-mediated diseases, with a market cap of $341.97 million.
Operations: Aldeyra Therapeutics focuses on developing and commercializing treatments for immune-mediated diseases. The company operates with a market cap of $341.97 million.
Aldeyra Therapeutics, with an expected revenue growth of 49.4% per year, has demonstrated significant progress in its R&D efforts, particularly with the recent Phase 3 trial success for reproxalap in treating dry eye disease (P=0.004). Despite a net loss increase to $16.85M from $8.99M YoY and high volatility over the past three months, Aldeyra's advancements in RASP modulators across multiple indications highlight its innovative potential within biotech. The company's forecasted earnings growth at 62.33% annually positions it as a transformative player amidst industry challenges and opportunities.
CSG Systems International
Simply Wall St Growth Rating: ★★★★☆☆
Overview: CSG Systems International, Inc., along with its subsidiaries, offers revenue management and digital monetization, customer experience, and payment solutions mainly to the communications industry across various regions including the Americas, Europe, the Middle East, Africa, and Asia Pacific; it has a market cap of approximately $1.37 billion.
Operations: CSG Systems International, Inc. generates revenue primarily through its data processing services, amounting to $1.17 billion. The company focuses on providing solutions for revenue management, digital monetization, customer experience, and payments within the communications sector across multiple global regions.